39 Total results for product and free and sample content found
Generics Bulletin: ジェネリック&バイオシミラーニュース
By David Wallace 08 Dec 2020
Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged
HBW Insight : コンシューマーヘルスケア産業のニュース
08 Dec 2020
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.
Topic EU OTC Drugs Coronavirus
Generics Bulletin: ジェネリック&バイオシミラーニュース
By David Wallace 29 Nov 2020
Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged.
HBW Insight : コンシューマーヘルスケア産業のニュース
By David Ridley 29 Nov 2020
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
Topic Coronavirus OTC Drugs EU
HBW Insight : コンシューマーヘルスケア産業のニュース
27 Nov 2020
An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.
Topic EU Market Intelligence
世界の薬事規制動向&情報を配信
27 Nov 2020
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
Topic EU Innovation Regulation
世界の薬事規制動向&情報を配信
By Ian Schofield 27 Nov 2020
Building more cold chain warehouses, finding alternative sources of medicine supplies, and halting parallel exports to mitigate product shortages. Just some of the ideas for tackling the consequences of a no-deal Brexit scenario put forward by industry representatives at a recent parliamentary committee hearing.
Topic Pharma-Brexit brexit EU
Medtech Insight: 世界の医療機器・医療技術の最新情報
27 Nov 2020
There has been quite a lot of conjecture over whether UK notified bodies would have to cease their CE marking operations on Brexit day, 31 January, or whether they would be able to continue until the end of the EU/UK withdrawal agreement. BSI's Gary Slack explains that BSI, for one, is still open for business.
No Records Found
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
*一部のサービスでは無料トライアルをご利用になれません。
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。
お問合せの際はフォームまたは下記メールアドレスをご利用頂くか、営業担当者の携帯電話までご連絡下さいますようご協力をお願い申し上げます。
インフォーマインテリジェンス合同会社
ファーマインテリジェンス
Eメール:inquiry.jp@informa.com
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。